Back to News
Market Impact: 0.3
IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence
Source: Nasdaq
M&A & RestructuringArtificial IntelligenceTechnology & InnovationHealthcare & Biotech
IDEXX Laboratories acquired CoVetAI, a provider of AI-native ambient listening and clinical workflow software for veterinary practices. Financial terms were not disclosed. The deal expands IDEXX's veterinary-practice technology capabilities and AI exposure, though the immediate financial impact cannot be assessed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
IDXX0.45
More News
- 'Hostile act': Trump threatens EU with tariffs over Canada associate-membership proposal
- US official says upcoming spectrum auctions could generate more than $100 billion
- Investors react to Fed hike and market sell-off: Brace for 'higher for longer' rates
- Fed delivers its first hike in 3 years. Plus, what's moving Starbucks and GE Vernova
- Fed’s Warsh lays out forces driving up bond yields
- The Fed unanimously agrees to hike interest rates for the first time since 2023, despite Trump’s call for the ‘lowest rates’ in the world
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?
- Earnings-Triggered Research Automations: A Control Guide